Supply Chain Ecosystem Analysis now part of DBMR Reports
Global Nanoparticles Market, By Technology (Liposomes, Nanotubes, Polymeric Nanoparticles, Polymer Conjugated Drugs, Dendrimers, Inorganic Nanoparticles, Others), Type of Analysis (Particle Size Analysis, Particle Concentration Analysis, Zeta Potential Analysis, Molecular Structure Analysis, Particle Shape Analysis, Others), End Use (Pharmaceuticals Industry, Biochemical Industry, Research Institutions, Others), Application (Biotechnology, Drug Development, Drug Delivery), Country (U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, U.A.E, Saudi Arabia, Egypt, South Africa, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029
Data Bridge Market Research analyses the nanoparticles market will exhibit a CAGR of 6.00% for the forecast period of 2022-2029.
Nanoparticles are extremely small materials that range in size from 1 to 100nm and have unique physical and chemical properties due to their extremely high surface area to volume ratio. Nanoparticles have a wide range of medicinal applications, including the treatment of brain tumours with chemotherapy drugs coupled to nanodiamonds. Using polymer-coated iron oxide nanoparticles to break up bacterial clusters also enables for more efficient treatment of chronic bacterial infections. Nanoparticles are commonly employed in cancer and inflammatory disease therapy to deliver drugs. The use of nanoparticle-based technologies has the potential to improve therapy efficacy.
The increasing focus on nanotechnology research will influence the growth rate of the nanoparticles market. The rising government investment in pharmaceutical research and development activities and expanding medical diagnostic industry are the key elements driving market expansion. The surge in the demand from various end-use industries will cushion the growth of nanoparticles market. The nanoparticles market is also being driven by factors such as increasing advantages in medicinal imaging applications and the surging growth in advance healthcare technology. Furthermore, increasing collaboration among private organization and government focusing on continuous advancement in nanoparticles technologies will enhance the growth rate of nanoparticles market. Also, increasing modernization and the rise in the prevalence of chronic disorders such as diabetes, cardiovascular diseases and cancer will act as major factors influencing the growth of nanoparticles market.
Moreover, expansion of end-user industries and untapped potential in emerging market will create beneficial opportunities for the growth of the nanoparticles market. Additionally, technological development as well as innovations focusing on utilization of nanotechnology in drug development and drug delivery processes for treatment and diagnosis purpose will provide lucrative opportunities for market’s growth.
However, high cost linked with nanoparticles analysis instruments will hamper the nanoparticles market’s growth rate. Also, hug capital investment for product development and R&D will further pose challenges to the growth of nanoparticles market. The advancement of methods for evaluating the toxicity of engineered nano-materials and development of tools to assess risk in human health and in the environment will act as market restrain and further impede the growth rate of nanoparticles market.
This nanoparticles market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographical expansions, technological innovations in the market. To gain more info on nanoparticles market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
The nanoparticles market is segmented on the basis of technology, type of analysis, end use and application. The growth amongst the different segments helps you in attaining the knowledge related to the different growth factors expected to be prevalent throughout the market and formulate different strategies to help identify core application areas and the difference in your target market.
The nanoparticles market is segmented on the basis of technology, type of analysis, end use and application.
The countries covered in the nanoparticles market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, Israel, Egypt, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the nanoparticles market and will continue to flourish its trend of dominance due to the increasing prevalence of chronic disorders such as diabetes, cardiovascular diseases and cancer in this region. Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to the rising government investment in pharmaceutical research and development activities in this region.
The country section of the nanoparticles market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
The nanoparticles market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to nanoparticles market.
Some of the major players operating in the nanoparticles market are Bristol-Myers Squibb Company, Johnson & Johnson Private Limited, Leadiant Biosciences, Inc., Malvern Panalytical Ltd, Novartis AG, Gilead Sciences, Inc., Johnson & Johnson Services, Inc., Amgen, Inc., Bruker, JEOL Ltd., Shimadzu Corporation, Agilent Technologies, Inc, Bruker Corporation, Hitachi, Ltd, Jeol Ltd, Microtrac Retsch GmbH, TSI, Wyatt Technology Corporation, HORIBA, Ltd., and Beckman Coulter, Inc., among others.
SKU-
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL NANOPARTICLES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL NANOPARTICLES MARKET SIZE
2.3 VENDOR POSITIONING GRID
2.4 MARKETS COVERED
2.5 GEOGRAPHIC SCOPE
2.6 YEARS CONSIDERED FOR THE STUDY
2.7 RESEARCH METHODOLOGY
2.8 TECHNOLOGY LIFE LINE CURVE
2.9 MULTIVARIATE MODELLING
2.1 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.11 DBMR MARKET POSITION GRID
2.12 MARKET APPLICATION COVERAGE GRID
2.13 DBMR MARKET CHALLENGE MATRIX
2.14 IMPORT AND EXPORT DATA
2.15 SECONDARY SOURCES
2.16 GLOBAL NANOPARTICLES MARKET: RESEARCH SNAPSHOT
2.17 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PRODUCTION CONSUMPTION ANALYSIS
5.2 IMPORT EXPORT SCENARIO
5.3 RAW MATERIAL PRODUCTION COVERAGE
5.4 TECHNOLOGICAL ADVANCEMENT BY MANUFACTURERS
5.5 LIST OF KEY BUYERS, BY REGION
5.5.1 NORTH AMERICA
5.5.2 EUROPE
5.5.3 ASIA PACIFIC
5.5.4 SOUTH AMERICA
5.5.5 MIDDLE EAST & AFRICA
5.6 PORTER’S FIVE FORCES
5.7 VENDOR SELECTION CRITERIA
5.8 PESTEL ANALYSIS
5.9 REGULATION COVERAGE
5.9.1 PRODUCT CODES
5.9.2 CERTIFIED STANDARDS
5.9.3 SAFETY STANDARDS
5.9.3.1. MATERIAL HANDLING & STORAGE
5.9.3.2. TRANSPORT & PRECAUTIONS
6 SUPPLY CHAIN ANALYSIS
6.1 OVERVIEW
6.2 LOGISTIC COST SCENARIO
6.3 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS
7 CLIMATE CHANGE SCENARIO
7.1 ENVIRONMENTAL CONCERNS
7.2 INDUSTRY RESPONSE
7.3 GOVERNMENT’S ROLE
7.4 ANALYST RECOMMENDATIONS
8 GLOBAL NANOPARTICLES MARKET, BY PRODUCT, 2020-2029, (KILO TONS) (USD MILLION)
8.1 OVERVIEW
8.2 LIPOSOMES
8.3 POLYMER-CONJUGATED DRUGS
8.4 POLYMERIC NANOPARTICLES
8.4.1 BY FORM
8.4.1.1. NANOSPHERES
8.4.1.2. NANOCAPSULES
8.4.2 BY CATEGORY
8.4.2.1. DAB
8.4.2.2. PAMAM
8.4.3 BY POLYMER
8.4.3.1. SYNTHETIC POLYMERS
8.4.3.1.1. PLA
8.4.3.1.2. PLGA
8.4.3.1.3. PCL
8.4.3.1.4. PICBA
8.4.3.1.5. PIHCA
8.4.3.1.6. OTHERS
8.4.3.2. NATURAL POLYMERS
8.4.3.2.1. CHITOSAN
8.4.3.2.2. ALGINATE
8.4.3.2.3. GELATIN
8.4.3.2.4. ALBUMIN
8.4.3.3. COPOLYMERS
8.4.3.3.1. PLA-PEG
8.4.3.3.2. PLGA-PEG
8.4.3.3.3. PCL-PEG
8.4.3.3.4. POLY (HDCA-PEGCA)
8.4.3.4. COLLOID STABILISERS
8.4.3.4.1. DEXTRAN
8.4.3.4.2. PLURONIC
8.4.3.4.3. POLY VINYL ALCOHOL
8.4.3.4.4. OTHERS
8.5 DENDRIMERS
8.6 INORGANIC NANOPARTICLES
8.6.1 BY SEGMENT
8.6.1.1. GOLD NANOPARTICLES
8.6.1.2. IRON OXIDE MAGNETIC NANOPARTICLE
8.6.1.3. OTHERS
8.7 OTHERS
9 GLOBAL NANOPARTICLES MARKET, BY APPLICATION, 2020-2029, (KILO TONS) (USD MILLION)
9.1 OVERVIEW
9.2 HEALTHCARE
9.2.1 BY SEGMENT
9.2.1.1. BIOTECHNOLOGY
9.2.1.2. DRUG DEVELOPMENT
9.2.1.3. DRUG DELIVERY
9.2.2 BY PRODUCT
9.2.2.1. LIPOSOMES
9.2.2.2. POLYMER-CONJUGATED DRUGS
9.2.2.3. POLYMERIC NANOPARTICLES
9.2.2.4. DENDRIMERS
9.2.2.5. INORGANIC NANOPARTICLES
9.2.2.6. OTHERS
9.3 PHARMACEUTICALS
9.3.1 BY PRODUCT
9.3.1.1. LIPOSOMES
9.3.1.2. POLYMER-CONJUGATED DRUGS
9.3.1.3. POLYMERIC NANOPARTICLES
9.3.1.4. DENDRIMERS
9.3.1.5. INORGANIC NANOPARTICLES
9.3.1.6. OTHERS
9.4 ELECTRONICS
9.4.1 BY PRODUCT
9.4.1.1. LIPOSOMES
9.4.1.2. POLYMER-CONJUGATED DRUGS
9.4.1.3. POLYMERIC NANOPARTICLES
9.4.1.4. DENDRIMERS
9.4.1.5. INORGANIC NANOPARTICLES
9.4.1.6. OTHERS
9.5 AUTOMOTIVE
9.5.1 BY PRODUCT
9.5.1.1. LIPOSOMES
9.5.1.2. POLYMER-CONJUGATED DRUGS
9.5.1.3. POLYMERIC NANOPARTICLES
9.5.1.4. DENDRIMERS
9.5.1.5. INORGANIC NANOPARTICLES
9.5.1.6. OTHERS
9.6 BUILDING & CONSTRUCTION
9.6.1 BY PRODUCT
9.6.1.1. LIPOSOMES
9.6.1.2. POLYMER-CONJUGATED DRUGS
9.6.1.3. POLYMERIC NANOPARTICLES
9.6.1.4. DENDRIMERS
9.6.1.5. INORGANIC NANOPARTICLES
9.6.1.6. OTHERS
9.7 PACKAGING
9.7.1 BY PRODUCT
9.7.1.1. LIPOSOMES
9.7.1.2. POLYMER-CONJUGATED DRUGS
9.7.1.3. POLYMERIC NANOPARTICLES
9.7.1.4. DENDRIMERS
9.7.1.5. INORGANIC NANOPARTICLES
9.7.1.6. OTHERS
9.8 AEROSPACE & DEFENCE
9.8.1 BY PRODUCT
9.8.1.1. LIPOSOMES
9.8.1.2. POLYMER-CONJUGATED DRUGS
9.8.1.3. POLYMERIC NANOPARTICLES
9.8.1.4. DENDRIMERS
9.8.1.5. INORGANIC NANOPARTICLES
9.8.1.6. OTHERS
9.9 OTHERS
9.9.1 BY PRODUCT
9.9.1.1. LIPOSOMES
9.9.1.2. POLYMER-CONJUGATED DRUGS
9.9.1.3. POLYMERIC NANOPARTICLES
9.9.1.4. DENDRIMERS
9.9.1.5. INORGANIC NANOPARTICLES
9.9.1.6. OTHERS
10 GLOBAL NANOPARTICLES MARKET, BY GEOGRAPHY, (USD MILLION)
10.1 GLOBAL NANOPARTICLES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
10.2 NORTH AMERICA
10.2.1 U.S.
10.2.2 CANADA
10.2.3 MEXICO
10.3 EUROPE
10.3.1 GERMANY
10.3.2 U.K.
10.3.3 ITALY
10.3.4 FRANCE
10.3.5 SPAIN
10.3.6 RUSSIA
10.3.7 SWITZERLAND
10.3.8 TURKEY
10.3.9 BELGIUM
10.3.10 NETHERLANDS
10.3.11 LUXEMBURG
10.3.12 REST OF EUROPE
10.4 ASIA-PACIFIC
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 SOUTH KOREA
10.4.4 INDIA
10.4.5 SINGAPORE
10.4.6 THAILAND
10.4.7 INDONESIA
10.4.8 MALAYSIA
10.4.9 PHILIPPINES
10.4.10 AUSTRALIA & NEW ZEALAND
10.4.11 REST OF ASIA-PACIFIC
10.5 SOUTH AMERICA
10.5.1 BRAZIL
10.5.2 ARGENTINA
10.5.3 REST OF SOUTH AMERICA
10.6 MIDDLE EAST AND AFRICA
10.6.1 SOUTH AFRICA
10.6.2 EGYPT
10.6.3 SAUDI ARABIA
10.6.4 UNITED ARAB EMIRATES
10.6.5 ISRAEL
10.6.6 REST OF MIDDLE EAST AND AFRICA
11 GLOBAL NANOPARTICLES MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: GLOBAL
11.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
11.3 COMPANY SHARE ANALYSIS: EUROPE
11.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
11.5 MERGERS AND ACQUISITIONS
11.6 NEW PRODUCT DEVELOPMENT AND APPROVALS
11.7 EXPANSIONS
11.8 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
12 SWOT AND DATA BRIDGE MARKET RESEARCH ANALYSIS
13 GLOBAL NANOPARTICLES MARKET - COMPANY PROFILES
13.1 NOVARTIS INTERNATIONAL AG
13.1.1 COMPANY SNAPSHOT
13.1.2 REVENUE ANALYSIS
13.1.3 PRODUCT PORTFOLIO
13.1.4 RECENT UPDATES
13.2 GILEAD SCIENCES, INC.
13.2.1 COMPANY SNAPSHOT
13.2.2 REVENUE ANALYSIS
13.2.3 PRODUCT PORTFOLIO
13.2.4 RECENT UPDATES
13.3 ABRAXIS BIOSCIENCES, INC.
13.3.1 COMPANY SNAPSHOT
13.3.2 REVENUE ANALYSIS
13.3.3 PRODUCT PORTFOLIO
13.3.4 RECENT UPDATES
13.4 SIGMA-TAU PHARMACEUTICALS, INC.
13.4.1 COMPANY SNAPSHOT
13.4.2 REVENUE ANALYSIS
13.4.3 PRODUCT PORTFOLIO
13.4.4 RECENT UPDATES
13.5 AMGEN, INC.
13.5.1 COMPANY SNAPSHOT
13.5.2 REVENUE ANALYSIS
13.5.3 PRODUCT PORTFOLIO
13.5.4 RECENT UPDATES
13.6 NANO INTERFACE TECHNOLOGY, INC.
13.6.1 COMPANY SNAPSHOT
13.6.2 REVENUE ANALYSIS
13.6.3 PRODUCT PORTFOLIO
13.6.4 RECENT UPDATES
13.7 ARKEMA
13.7.1 COMPANY SNAPSHOT
13.7.2 REVENUE ANALYSIS
13.7.3 PRODUCT PORTFOLIO
13.7.4 RECENT UPDATES
13.8 NANOPHASE TECHNOLOGIES CORPORATION
13.8.1 COMPANY SNAPSHOT
13.8.2 REVENUE ANALYSIS
13.8.3 PRODUCT PORTFOLIO
13.8.4 RECENT UPDATES
13.9 CABOT CORPORATION
13.9.1 COMPANY SNAPSHOT
13.9.2 REVENUE ANALYSIS
13.9.3 PRODUCT PORTFOLIO
13.9.4 RECENT UPDATESA
13.1 ZYVEX INSTRUMENTS
13.10.1 COMPANY SNAPSHOT
13.10.2 REVENUE ANALYSIS
13.10.3 PRODUCT PORTFOLIO
13.10.4 RECENT UPDATES
13.11 NANOSHEL LLC
13.11.1 COMPANY SNAPSHOT
13.11.2 REVENUE ANALYSIS
13.11.3 PRODUCT PORTFOLIO
13.11.4 RECENT UPDATES
13.12 APHIOS CORPORATION
13.12.1 COMPANY SNAPSHOT
13.12.2 REVENUE ANALYSIS
13.12.3 PRODUCT PORTFOLIO
13.12.4 RECENT UPDATES
13.13 CD BIOPARTICLES
13.13.1 COMPANY SNAPSHOT
13.13.2 REVENUE ANALYSIS
13.13.3 PRODUCT PORTFOLIO
13.13.4 RECENT UPDATES
13.14 PHOSPHOREX, INC.
13.14.1 COMPANY SNAPSHOT
13.14.2 REVENUE ANALYSIS
13.14.3 PRODUCT PORTFOLIO
13.14.4 RECENT UPDATES
13.15 MERCK KGAA
13.15.1 COMPANY SNAPSHOT
13.15.2 REVENUE ANALYSIS
13.15.3 PRODUCT PORTFOLIO
13.15.4 RECENT UPDATES
13.16 DSM
13.16.1 COMPANY SNAPSHOT
13.16.2 REVENUE ANALYSIS
13.16.3 PRODUCT PORTFOLIO
13.16.4 RECENT UPDATES
13.17 STATNANO
13.17.1 COMPANY SNAPSHOT
13.17.2 REVENUE ANALYSIS
13.17.3 PRODUCT PORTFOLIO
13.17.4 RECENT UPDATES
13.18 PRECISION NANOSYSTEMS
13.18.1 COMPANY SNAPSHOT
13.18.2 REVENUE ANALYSIS
13.18.3 PRODUCT PORTFOLIO
13.18.4 RECENT UPDATES
13.19 NANOCOMPOSIX
13.19.1 COMPANY SNAPSHOT
13.19.2 REVENUE ANALYSIS
13.19.3 PRODUCT PORTFOLIO
13.19.4 RECENT UPDATES
13.2 ARDENA HOLDING NV
13.20.1 COMPANY SNAPSHOT
13.20.2 REVENUE ANALYSIS
13.20.3 PRODUCT PORTFOLIO
13.20.4 RECENT UPDATES
13.21 ALFA AESAR
13.21.1 COMPANY SNAPSHOT
13.21.2 REVENUE ANALYSIS
13.21.3 PRODUCT PORTFOLIO
13.21.4 RECENT UPDATES
13.22 GRAY
13.22.1 COMPANY SNAPSHOT
13.22.2 REVENUE ANALYSIS
13.22.3 PRODUCT PORTFOLIO
13.22.4 RECENT UPDATES
13.23 SRL
13.23.1 COMPANY SNAPSHOT
13.23.2 REVENUE ANALYSIS
13.23.3 PRODUCT PORTFOLIO
13.23.4 RECENT UPDATES
13.24 NANORH
13.24.1 COMPANY SNAPSHOT
13.24.2 REVENUE ANALYSIS
13.24.3 PRODUCT PORTFOLIO
13.24.4 RECENT UPDATES
13.25 ELEMENTIS SPECIALTIES
13.25.1 COMPANY SNAPSHOT
13.25.2 REVENUE ANALYSIS
13.25.3 PRODUCT PORTFOLIO
13.25.4 RECENT UPDATES
*NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
14 RELATED REPORTS
15 QUESTIONNAIRE
16 CONCLUSION
17 ABOUT DATA BRIDGE MARKET RESEARCH
To support market growth and help clients navigate the impact of geopolitical shifts, DBMR has integrated in-depth supply chain analysis into its Global Nanoparticles Market research reports. This addition empowers clients to respond effectively to global changes affecting their industries. The supply chain analysis section includes detailed insights such as Global Nanoparticles Market consumption and production by country, price trend analysis, the impact of tariffs and geopolitical developments, and import and export trends by country and HSN code. It also highlights major suppliers with data on production capacity and company profiles, as well as key importers and exporters. In addition to research, DBMR offers specialized supply chain consulting services backed by over a decade of experience, providing solutions like supplier discovery, supplier risk assessment, price trend analysis, impact evaluation of inflation and trade route changes, and comprehensive market trend analysis.
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.